A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or na ïve Subjects Not Part of H03_01TP Study

Condition:   Dysentery, Bacillary Intervention:   Biological: GVGH Shigella sonnei 1790GAHB vaccine Sponsor:   GlaxoSmithKline Recruiting - verified March 2017

Source: ClinicalTrials.gov - March 21, 2017 Category: Research Source Type: clinical trials